Nuvation Bio Inc (NUVB)

Feb 13, 2026

Nuvation Bio Inc. (NYSE:NUVB) Is Expected To Breakeven In The Near Future - 富途牛牛

Feb 13, 2026

Feb 13, 2026

Nuvation Bio Inc. (NUVB) Stock Analysis: Unveiling a 105% Potential Upside in Biotech Innovation - DirectorsTalk Interviews

Feb 13, 2026

Feb 12, 2026

Will Nuvation Bio Inc. stock return to pre crisis levels2025 Geopolitical Influence & Technical Entry and Exit Tips - mfd.ru

Feb 12, 2026

Feb 12, 2026

Published on: 2026-02-12 23:17:55 - mfd.ru

Feb 12, 2026

Feb 10, 2026

Forecasting The Future: 9 Analyst Projections For Nuvation Bio - Benzinga

Feb 10, 2026

Feb 10, 2026

Nuvation Bio's (NUVB) Outperform Rating Reaffirmed at Wedbush - MarketBeat

Feb 10, 2026

Feb 10, 2026

Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial (G203) for Safusidenib in IDH1-Mutant Glioma - BioSpace

Feb 10, 2026

Feb 10, 2026

Nuvation Bio expands SIGMA trial to phase 3 for IDH1-mutant glioma - Investing.com Canada

Feb 10, 2026

Feb 09, 2026

Nuvation Bio announces pivotal global phase 3 Sigma trial (G203) for Safusidenib in IDH1-mutant glioma - marketscreener.com

Feb 09, 2026

Feb 09, 2026

Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial for Safusidenib in IDH1-Mutant Glioma - Investing News Network

Feb 09, 2026

Feb 06, 2026

S P Trends: Is Nuvation Bio Inc stock undervalued right nowPrice Action & Long-Term Investment Growth Plans - baoquankhu1.vn

Feb 06, 2026

Feb 06, 2026

Nuvation Bio Inc. (NUVB) Stock Analysis: Exploring 111.55% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Feb 06, 2026

Feb 04, 2026

Nuvation Bio stock maintains Buy rating at B.Riley on Ibtrozi sales momentum - Investing.com Nigeria

Feb 04, 2026

Feb 02, 2026

Analyst Endorsements Of Ibtrozi Uptake Could Be A Game Changer For Nuvation Bio (NUVB) - Sahm

Feb 02, 2026

Feb 02, 2026

Nuvation Bio: Rollout Data Of Ibtrozi Support A Modest Buy (NYSE:NUVB) - Seeking Alpha

Feb 02, 2026

Feb 01, 2026

Assessing Nuvation Bio (NUVB) Valuation After Bullish Analyst Calls On Ibtrozi And mIDH1 Glioma Potential - Yahoo Finance

Feb 01, 2026

Jan 30, 2026

Turist Financial Remains a Buy on Nuvation Bio (NUVB) - Finviz

Jan 30, 2026

Jan 30, 2026

Truist Highlights Nuvation Bio’s (NUVB) Ibtrozi’s Robust Market Uptake and Lead Over Competitors - Insider Monkey

Jan 30, 2026

Jan 28, 2026

11 Best High Short Interest Stocks With Biggest Upside Potential - Insider Monkey

Jan 28, 2026

Jan 28, 2026

Nuvation Bio price target raised to $13 from $11 at Truist - Yahoo Finance

Jan 28, 2026

Jan 28, 2026

Truist Securities raises Nuvation Bio stock price target to $13 on Ibtrozi uptake - Investing.com Nigeria

Jan 28, 2026

Jan 26, 2026

Nuvation Bio Inc. (NUVB) price target lowered as IBTROZI sales meet expectations - MSN

Jan 26, 2026

Jan 25, 2026

Is Nuvation Bio Inc. stock undervalued right now2025 Earnings Surprises & Free AI Powered Buy and Sell Recommendations - mfd.ru

Jan 25, 2026

Jan 25, 2026

Assessing Nuvation Bio (NUVB) Valuation After The Eisai Taletrectinib Partnership Announcement - Sahm

Jan 25, 2026

Jan 24, 2026

JonesTrading Sticks to Their Buy Rating for Nuvation Bio (NUVB) - The Globe and Mail

Jan 24, 2026

Jan 24, 2026

JonesTrading Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $12 - 富途资讯

Jan 24, 2026

Jan 23, 2026

Nuvation Bio Inc. (NYSE:NUVB) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Jan 23, 2026

Jan 23, 2026

Nuvation Bio Inc. (NUVB) Stock Analysis: 97% Potential Upside with Promising Oncology Pipeline - DirectorsTalk Interviews

Jan 23, 2026

Jan 22, 2026

Nuvation Bio (NYSE:NUVB) Stock Price Down 4.2%Here's Why - MarketBeat

Jan 22, 2026

Jan 21, 2026

Why Nuvation Bio (NUVB) Is Down 8.2% After Expanding Global Taletrectinib Partnership With Eisai - simplywall.st

Jan 21, 2026

Jan 20, 2026

Nuvation Bio Inc. (NUVB) Price Target Lowered as IBTROZI Sales Meet Expectations - Yahoo Finance

Jan 20, 2026

Jan 19, 2026

Top 10 Oncology Stocks to Buy Now - Insider Monkey

Jan 19, 2026

Jan 19, 2026

Here’s What the Wall Street Thinks About Nuvation Bio Inc. (NUVB) - Insider Monkey

Jan 19, 2026

Jan 19, 2026

Here's What the Wall Street Thinks About Nuvation Bio Inc. (NUVB) - Finviz

Jan 19, 2026

Jan 18, 2026

10 Stocks Under $10 with High Potential - Insider Monkey

Jan 18, 2026

Jan 17, 2026

Aug Closing: Whats the analyst consensus on Surrozen IncLong Setup & Fast Exit and Entry Strategy Plans - baoquankhu1.vn

Jan 17, 2026

Jan 17, 2026

Is Nuvation Bio (NUVB) Pricing In Its Sharp Swings Or A Long Runway For Growth - Yahoo Finance

Jan 17, 2026

Jan 16, 2026

Signal Recap: Should I invest in KORE Group Holdings Inc before earningsJuly 2025 Earnings & Fast Moving Stock Trade Plans - baoquankhu1.vn

Jan 16, 2026

Jan 16, 2026

A Look At Nuvation Bio (NUVB) Valuation After The Eisai Taletrectinib Licensing Deal - Yahoo Finance

Jan 16, 2026

Jan 16, 2026

A Look At Nuvation Bio’s Valuation After The Eisai Taletrectinib Collaboration Agreement - Sahm

Jan 16, 2026

Jan 16, 2026

Is Nuvation Bio Inc stock undervalued right nowMarket Growth Report & Risk Controlled Daily Trade Plans - baoquankhu1.vn

Jan 16, 2026

Jan 16, 2026

Eisai and Nuvation Bio ink licensing deal for taletrectinib - The Pharma Letter

Jan 16, 2026

Jan 15, 2026

14 Best Booming Stocks to Buy Right Now - Insider Monkey

Jan 15, 2026

Jan 15, 2026

Nuvation Bio Inc. (NUVB) Announces Exclusive Licensing Agreement With Eisai to Expand Global Reach of Taletrectinib - Insider Monkey

Jan 15, 2026